Literature DB >> 6580529

Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line.

P Nowell, J Finan, R Dalla-Favera, R C Gallo, A ar-Rushdi, H Romanczuk, J R Selden, B S Emanuel, G Rovera, C M Croce.   

Abstract

Several unusual chromosome structures have been described in drug-resistant cell lines and in certain tumours. These structures include elongated homogeneously staining regions (HSRs), small extrachromosomal paired chromatin bodies (double minutes, DMs) and abnormally banded regions (ABRs) with strong but anomalous band patterns. There is evidence that these are alternative forms of gene amplification, with HSRs breaking down to form DMs, and DMs integrating into the chromosome to generate HSRs and ABRs. Recently, it was demonstrated that, compared with several normal and leukaemia human cells, DNA sequences representing the human homologue of the onc gene of the avian myelocytomatosis virus (MC29), the so-called c-myc gene, were amplified in HL-60 cells. This is a human promyelocytic leukaemia cell line established in the laboratory of one of us (R.C.G.) at the National Cancer Institute (Bethesda, Maryland) in 1977, and widely used for studies on myeloid and monocytic differentiation. Amplification of the gene was present in primary leukaemic cells of the patient, and DMs were noted in some of these cells as well as in early passages of the HL-60 line. No structure resembling HSRs or ABRs were noted in karyotypic studies at this early stage and there were no alterations involving the long arm of chromosome 8 (8q), to which the c-myc gene has recently been mapped. We have now re-examined the karyotype of the HL-60 line, using cells frozen at various times during its continuous passage at the Wistar Institute (Philadelphia, Pennsylvania) to look for chromosomal abnormalities that might be associated with the amplification of c-myc. We find that, beginning in 1979, HL-60 cells at the Wistar Institute no longer had DMs, but did show an abnormal 8q+ chromosome, replacing a normal chromosome 8, and representing an ABR reflecting the site of myc gene amplification.

Entities:  

Mesh:

Year:  1983        PMID: 6580529     DOI: 10.1038/306494a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

Review 1.  The legacy of the Philadelphia chromosome.

Authors:  Gary A Koretzky
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Clinical implications of the cancer genome.

Authors:  Laura E Macconaill; Levi A Garraway
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

3.  Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription.

Authors:  M Krönke; C Schlüter; K Pfizenmaier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 4.  The HL60 cell line: a model system for studying human myeloid cell differentiation.

Authors:  G D Birnie
Journal:  Br J Cancer Suppl       Date:  1988-12

5.  Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells.

Authors:  M Shibuya; J Yokota; Y Ueyama
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

6.  Chromosomes, genes, and cancer.

Authors:  P C Nowell; C M Croce
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

7.  History and present status of human chromosome studies.

Authors:  J H Tjio; W W Nichols
Journal:  In Vitro Cell Dev Biol       Date:  1985-06

8.  Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S.

Authors:  D Cherif; C Lavialle; N Modjtahedi; M Le Coniat; R Berger; O Brison
Journal:  Chromosoma       Date:  1989-01       Impact factor: 4.316

Review 9.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.

Authors:  Jinfei Xu; Joseph R Testa
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.